Cite
HARVARD Citation
Nam, Y. et al. (2021). Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting. Thoracic cancer. 12 (6), pp. 890-898. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nam, Y. et al. (2021). Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting. Thoracic cancer. 12 (6), pp. 890-898. [Online].